Nuveen LLC Invests $61.79 Million in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

Key Points

• Nuveen LLC acquired a new stake in Sabra Healthcare REIT, purchasing approximately $61.79 million worth of shares in the first quarter, representing a 1.49% ownership of the company.
• Wall Street analysts have raised their price targets for Sabra Healthcare REIT, with JMP Securities setting a new target of $22.00 and three analysts rating the stock with a "buy" or higher rating.
• Sabra Healthcare REIT recently declared a quarterly dividend of $0.30 per share, resulting in a 6.5% dividend yield, with its dividend payout ratio at 157.89%.

Nuveen LLC purchased a new stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 3,536,999 shares of the real estate investment trust's stock, valued at approximately $61,791,000. Nuveen LLC owned 1.49% of Sabra Healthcare REIT as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. UMB Bank n.a. increased its position in shares of Sabra Healthcare REIT by 379.6% during the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock valued at $36,000 after purchasing an additional 1,621 shares during the period. Assetmark Inc. increased its position in shares of Sabra Healthcare REIT by 37.8% during the 1st quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust's stock valued at $63,000 after purchasing an additional 989 shares during the period. Fifth Third Bancorp increased its position in shares of Sabra Healthcare REIT by 110.3% during the 1st quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust's stock valued at $67,000 after purchasing an additional 2,011 shares during the period. GF Fund Management CO. LTD. acquired a new position in shares of Sabra Healthcare REIT during the 4th quarter valued at $74,000. Finally, Harbor Capital Advisors Inc. increased its position in shares of Sabra Healthcare REIT by 17.2% during the 1st quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock valued at $76,000 after purchasing an additional 642 shares during the period. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of the firm's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the transaction, the director directly owned 64,725 shares in the company, valued at $1,179,289.50. This trade represents a 14.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.20% of the stock is currently owned by company insiders.

Sabra Healthcare REIT Stock Up 0.1%

SBRA traded up $0.01 during trading on Friday, reaching $18.46. 2,862,912 shares of the stock traded hands, compared to its average volume of 2,604,435. The stock has a market cap of $4.43 billion, a price-to-earnings ratio of 24.29, a price-to-earnings-growth ratio of 1.53 and a beta of 0.86. Sabra Healthcare REIT, Inc. has a fifty-two week low of $15.60 and a fifty-two week high of $20.03. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. The stock's 50-day simple moving average is $18.33 and its two-hundred day simple moving average is $17.61.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. The firm had revenue of $189.15 million during the quarter, compared to analysts' expectations of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%. The business's revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.36 earnings per share. As a group, equities research analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Friday, August 15th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.5%. The ex-dividend date is Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio (DPR) is 157.89%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Scotiabank lifted their price target on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. JMP Securities raised their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $20.00.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.